Results 111 to 120 of about 3,139,231 (313)

Aggressive prostate cancer is associated with pericyte dysfunction

Molecular Oncology, EarlyView.
Tumor‐produced TGF‐β drives pericyte dysfunction in prostate cancer. This dysfunction is characterized by downregulation of some canonical pericyte markers (i.e., DES, CSPG4, and ACTA2) while maintaining the expression of others (i.e., PDGFRB, NOTCH3, and RGS5).
Anabel Martinez‐Romero, Ane Martinez‐Larrinaga, Joaquim Grego‐Bessa, Saioa Garcia‐Longarte, Hielke van Splunder, Ianire Astobiza, Amaia Ercilla, Laura Bozal‐Basterra, Isabel Mendizabal, Pilar Villacampa, Arkaitz Carracedo, Mariona Graupera   +11 more
wiley   +1 more source

Catheter embolization for pulmonary arteriovenous malformations during chemotherapy for appendiceal adenocarcinoma: A case report of associated brain abscess

Radiology Case Reports
Pulmonary arteriovenous malformations are rare, abnormal, low-resistance vascular structures that connect a pulmonary artery to a vein. They are common in patients with hereditary hemorrhagic telangiectasia; however, acquired malformations can occur in ...
Toshinari Yagi, MD, Koji Takano, MD, PhD, Toru Umehara, MD, PhD, Hideyuki Arita, MD, PhD, Noboru Maeda, MD, PhD, Katsuyuki Nakanishi, MD, PhD   +5 more
doaj   +1 more source

Peer Review #3 of "A pan-cancer analysis of prognostic genes (v0.2)"

, 2016
Jordan Anaya, R Akbani, P Ng, H Werner, M Shahmoradgoli, F Zhang, Z Ju, W Liu, J Yang, K Yoshihara, J Li, S Ling, E Seviour, P Ram, J Minna, L Diao, P Tong, J Heymach, S Hill, F Dondelinger, N Stadler, L Byers, F Meric-Bernstam, J Weinstein, B Broom, R Verhaak, H Liang, S Mukherjee, Y Lu, G Mills, B Bange, E Zwick, A Ullrich, C Brennan, R Verhaak, A Mckenna, B Campos, H Noushmehr, S Salama, S Zheng, D Chakravarty, J Sanborn, S Berman, R Beroukhim, B Bernard, C Wu, G Genovese, I Shmulevich, J Barnholtz-Sloan, L Zou, R Vegesna, S Shukla, G Ciriello, W Yung, W Zhang, C Sougnez, T Mikkelsen, K Aldape, D Bigner, E Van Meir, M Prados, A Sloan, K Black, J Eschbacher, G Finocchiaro, W Friedman, D Andrews, A Guha, M Iacocca, O' Neill, B Foltz, G Myers, J Weisenberger, D Penny, R Kucherlapati, R Perou, C Hayes, D Gibbs, R Marra, M Mills, G Lander, E Spellman, P Wilson, R Sander, C Weinstein, J Meyerson, M Gabriel, S Laird, P Haussler, D Getz, G Chin, L Network Tr, Cancer Genome Atlas, N, Cancer Genome, Atlas Research, N Kandoth, C Schultz, N Cherniack, A Akbani   +99 more
openalex   +2 more sources

The neural crest‐associated gene ERRFI1 is involved in melanoma progression and resistance toward targeted therapy

Molecular Oncology, EarlyView.
ERRFI1, a neural crest (NC)‐associated gene, was upregulated in melanoma and negatively correlated with the expression of melanocytic differentiation markers and the susceptibility of melanoma cells toward BRAF inhibitors (BRAFi). Knocking down ERRFI1 significantly increased the sensitivity of melanoma cells to BRAFi.
Nina Wang, Qian Sun, Daniel Novak, Lei Zhu, Juliane Poelchen, Tamara Steinfass, Yiman Wang, Viktor Umansky, Jochen Utikal   +8 more
wiley   +1 more source

Peer Review #3 of "Tumor-preventing activity of aspirin in multiple cancers based on bioinformatic analyses (v0.2)"

, 2018

openalex   +1 more source

Long non-coding RNA LINC00511 regulates the expression of microRNA-625-5p and activates signal transducers and activators of transcription 3 (STAT3) to accelerate the progression of gastric cancer

, 2021
Ning Cui, Qinhui Sun, Hongjun Liu, Leping Li, Xiaobo Guo, Yulong Shi, Changqing Jing, Chengkun Qin, Yu Zhao   +8 more
openalex   +1 more source

Plasma extrachromosomal circular DNA as a biomarker in EGFR‐targeted therapy of non‐small cell lung cancer

Molecular Oncology, EarlyView.
Detection of extrachromosomal circular DNA (eccDNA) in plasma samples from EGFR‐mutated non‐small cell lung cancer patients. Plasma was collected before and during treatment with the EGFR‐tyrosine kinase inhibitor osimertinib. Plasma eccDNA was detected in all cancer samples, and the presence of the EGFR gene on eccDNA serves as a potential biomarker ...
Simone Stensgaard, Sarmad Mehmood, Eva Boysen Fynboe Ebert, Peter Meldgaard, Anindya Dutta, Boe S. Sorensen   +5 more
wiley   +1 more source

Additional file 3 of Computational quantification and characterization of independently evolving cellular subpopulations within tumors is critical to inhibit anti-cancer therapy resistance

, 2022
Heba Alkhatib, Ariel M. Rubinstein, Swetha Vasudevan, Efrat Flashner-Abramson, Shira Stefansky, Sangita Roy Chowdhury, Solomon Oguche, Tamar Peretz-Yablonsky, Avital Granit, Zvi Granot, Ittai Ben‐Porath, Kim Sheva, J. D. Feldman, Noa Cohen, Amichay Meirovitz, Nataly Kravchenko‐Balasha   +15 more
openalex   +1 more source

Cytoplasmic p21 promotes stemness of colon cancer cells via activation of the NFκB pathway

Molecular Oncology, EarlyView.
Cytoplasmic p21 promotes colorectal cancer stem cell (CSC) features by destabilizing the NFκB–IκB complex, activating NFκB signaling, and upregulating BCL‐xL and COX2. In contrast to nuclear p21, cytoplasmic p21 enhances spheroid formation and stemness transcription factor CD133.
Arnatchai Maiuthed, Kerstin Huebner, Katharina Erlenbach‐Wuensch, Chuanpit Hampel, Daniela Thalheim, Adriana Vial‐Roehe, Bodee Nutho, Susanne Merkel, Arndt Hartmann, Pithi Chanvorachote, Regine Schneider‐Stock   +10 more
wiley   +1 more source

Additional file 3 of Gene expression predicts dormant metastatic breast cancer cell phenotype

, 2022
Qihao Ren, Weng Hua Khoo, Alexander P. Corr, Tri Giang Phan, Peter I. Croucher, Sheila A. Stewart   +5 more
openalex   +1 more source